Faculty Opinions recommendation of Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials.
2014 ◽
Vol 38
(9)
◽
pp. 1048-1054
◽
2017 ◽
Vol 113
◽
pp. 249-255
◽